NCT02725424 2022-08-17
MATCH
ChineseAMS
Phase 2 Completed
Clinical Trials
4 trialsNCT05318339 2022-04-08
A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma
ChineseAMS
Phase 2 Unknown
NCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
NCT05020964 2021-08-25
Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
ChineseAMS
Phase 2 Unknown